Trial intelligence / Profile preview

Pilot study of transdermal lidocaine patch use for bruxism

RBR-3n8w4pcCompleted

Sponsor
Pontifícia Universidade Católica de São Paulo
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of lidocaine in bruxism and temporomandibular disorder (TMD), sponsored by Pontifícia Universidade Católica de São Paulo. Started Jan 2024; status: completed.

02

Drugs

lidocaine
03

Conditions

bruxismtemporomandibular disorder (TMD)

Beyond the preview

Go deeper on RBR-3n8w4pc.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3n8w4pc.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call